Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,337,975
+$3,834,822 QoQ
Shares Held
543,582
+206.3% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,100,351,284 across 114 Biotechnology names. OCUL ranks #33 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | 397,000 | $52,693,809 | |||
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in OCUL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,337,975 | 543,582 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,503,153 | 177,468 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $559,520 | 46,089 | Shares | Defined | 2026-02-17 | |
| 2024-03-31 | $196,041 | 21,543 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $50,262 | 16,007 | Principal | Defined | 2023-11-14 | |
| 2021-12-31 | $745,580 | 106,970 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||